ED
ESRX

Exane Derivatives’s Express Scripts Holding Company ESRX Stock Holding History

Exane Derivatives’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-712
Closed -$67.4K – 761
2018
Q3 		$67.4K Buy
712
+705
+10,071% +$60.1K 0.01% 355
2018
Q2 		$543 Sell
7
-16,304
-100% -$1.22M ﹤0.01% 561
2018
Q1 		$1.14M Buy
+16,311
New +$1.24M 0.23% 115

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.41B AUM 14.87% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Exane Derivatives's ESRX Position: Q4 2018 in Review

Exane Derivatives sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 712 shares — an estimated $67.4K sold.

Exane Derivatives first reported a position in ESRX in Q1 2018 and held it in 3 quarters. The position peaked at $1.14M in Q1 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Exane Derivatives reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 712 Express Scripts Holding Company shares in Q4 2018, an estimated $67.4K.
  • Exane Derivatives first reported a position in Express Scripts Holding Company in Q1 2018 and held it in 3 quarters.
  • Exane Derivatives's Express Scripts Holding Company position peaked at $1.14M in Q1 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.